UPEXI, INC. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by UPEXI, INC. (UPXI), a Delaware corporation listed on NASDAQ, with a report date of December 2, 2025. The filing primarily addresses a private placement offering and upcoming investor conference participation.
Key Financial Metrics
The filing details a capital raise event rather than periodic operating results. Key financial figures include:
- Aggregate Gross Proceeds: Approximately $10 million from the private placement.
- Securities Issued: 3,289,474 shares of common stock and warrants to purchase up to 3,289,474 shares.
- Purchase Price: Combined price of $3.04 per share and warrant.
- Potential Additional Proceeds: Approximately $13 million upon cash exercise of warrants.
- Net Proceeds: Not explicitly stated; proceeds are before deducting placement agent fees and offering expenses.
The filing does not provide data on revenue, profit, cash flow, margins, or existing debt levels.
Material Changes
The primary material change is the increase in equity capital and the potential dilution from the issuance of 3,289,474 new shares and corresponding warrants. No comparative financial period data is provided in this document to assess changes in operating performance.
Outlook, Risks, and Management Commentary
Management announced participation in three investor conferences in December 2025 to discuss the company's strategy. The filing notes that the press releases attached as exhibits are furnished and not deemed "filed" for purposes of Section 18 of the Exchange Act, limiting their incorporation by reference in future filings unless explicitly cited.
Investor Verification Checklist
- Verify the final net proceeds after deducting placement agent fees and offering expenses.
- Review the specific terms of the warrants (exercise price, expiration date, and conditions) in the attached press release (Exhibit 99.1).
- Confirm the impact of the new share issuance on existing shareholder dilution.
- Check for any subsequent filings regarding the use of proceeds from the $10 million raise.